reserpine has been researched along with benzofurans in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (52.63) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christensen, AV; Danneskiold-Samsoe, P; Fjalland, B; Pedersen, V; Svendsen, O | 1 |
| Hansen, V; Hjortkjaer, J; Holmblad, J; Hougs, W; Huld, T; Jorgensen, A; Lassen, N; Nielsen, IM; Nymark, M; Pedersen, V; Petersen, PV | 1 |
| Leonard, BE | 1 |
| Lippmann, W | 1 |
| Fujimoto, M; Hirose, N; Kitahara, A; Miyao, K; Ogo, T | 1 |
| Fujimoto, M; Kitahara, A; Miyao, K; Ogo, T | 1 |
| Nielsen, IM | 1 |
| Broadley, KJ; Nicholson, CD | 1 |
| Broadley, KJ; Williams, RG | 1 |
| Krstew, E; Malta, E; McPherson, GA; Molenaar, P; Raper, C | 1 |
| Brotchie, JM; Crossman, AR; Maneuf, YP; Mitchell, IJ; Woodruff, GN | 1 |
| Brotchie, JM; Crossman, AR; Hill, MP; Hughes, NR; McKnight, AT; Woodruff, GN | 1 |
| Chou, YH; Farde, L; Halldin, C; Karlsson, P; Olsson, H | 1 |
| Brotchie, JM; Hill, MP | 1 |
| Akaike, A; Katsuki, H; Knoll, J; Shimazu, S; Takahata, K; Tanigawa, A; Tsunekawa, H; Yoneda, F | 1 |
| Knoll, J; Shimazu, S; Tamashiro, A; Yoneda, F | 1 |
| Abi-Dargham, A; Guo, N; Huang, YY; Hwang, DR; Laruelle, M; Lo, ES | 1 |
| Hashimoto, M; Ono, H; Tanabe, M | 1 |
| Li, JX; Seaman, RW; Shang, L; Siemian, JN; Zhang, Y; Zhu, Q | 1 |
19 other study(ies) available for reserpine and benzofurans
| Article | Year |
|---|---|
Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents, Tricyclic; Benzofurans; Body Temperature; Depression, Chemical; Dogs; Drug Interactions; Female; Histamine H1 Antagonists; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Nitriles; Parasympatholytics; Rabbits; Rats; Reserpine; Serotonin; Species Specificity; Tetrabenazine; Tryptophan | 1977 |
Pharmacological studies of a new series of bicyclic thymoleptics.
Topics: Amitriptyline; Amphetamine; Animals; Antidepressive Agents; Atropine; Behavior, Animal; Benzofurans; Cocaine; Drug Antagonism; Drug Synergism; Guinea Pigs; Heterocyclic Compounds; Ileum; Indoles; Male; Methadone; Mice; Norepinephrine; Oxazines; Parasympatholytics; Polycyclic Compounds; Quinolines; Reserpine | 1966 |
The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursors.
Topics: Animals; Anticonvulsants; Benzene Derivatives; Benzofurans; Biogenic Amines; Body Temperature; Brain; Dextroamphetamine; Dimethylamines; Electroshock; Hexobarbital; Ketones; Lethal Dose 50; Methyltyrosines; Mice; Norepinephrine; Oxotremorine; Pentylenetetrazole; Rats; Reserpine; Salivation; Serotonin; Sleep; Tyramine | 1972 |
Aspects of the gastric acid antisecretory activity of 3,3-dimethyl-1-(3-methylaminopropyl)-1-phenylphthalan: a blocker of norepinephrine uptake.
Topics: Animals; Antacids; Benzofurans; Bridged-Ring Compounds; Depression, Chemical; Desipramine; Drug Antagonism; Female; Gastric Juice; Histamine; Imipramine; Methyltyrosines; Norepinephrine; Peptides; Rats; Reserpine; Stomach Ulcer; Structure-Activity Relationship; Succinates; Tranquilizing Agents | 1971 |
MOde of action of analgesic effect of 2-methylaminomethyl-2,3-dihydrobenzofuran (EPS-4032).
Topics: Analgesics; Animals; Benzofurans; Levallorphan; Male; Mice; Morphine; Nialamide; Reserpine; Tetrabenazine | 1971 |
[Analgesic effect of 2-methylaminoethyl 2,3-dihydrobenzofuran (EPS-4032); mode of action in mice].
Topics: 5-Hydroxytryptophan; Aminopyrine; Analgesics; Animals; Benzofurans; Dihydroxyphenylalanine; Drug Antagonism; Drug Synergism; Drug Tolerance; Lethal Dose 50; Levallorphan; Male; Mice; Morphine; Nialamide; Pargyline; Phenobarbital; Proadifen; Reserpine; Tetrabenazine; Time Factors | 1971 |
Lu 3-olo (3,3 dimethyl-1-phenyl-1,3 methylaminopropylphthalane): pharmacological profile.
Topics: Animals; Antidepressive Agents; Benzofurans; Catecholamines; Mice; Rats; Reserpine | 1967 |
The use of an irreversible beta-adrenoreceptor antagonist to examine reserpine- and hypothermia-induced supersensitivity of guinea-pig atria.
Topics: Adrenergic beta-Antagonists; Animals; Benzofurans; Female; Guinea Pigs; Heart; Heart Rate; Hypothermia; In Vitro Techniques; Male; Metaproterenol; Myocardial Contraction; Reserpine | 1980 |
Determination of agonist affinity for cardiac beta-adrenoceptors during reserpine-induced supersensitivity.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Benzofurans; Carbachol; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Metaproterenol; Myocardium; Papillary Muscles; Receptors, Adrenergic; Receptors, Adrenergic, beta; Reserpine | 1983 |
Is Ro 03-7894 an irreversible antagonist at beta-adrenoceptor sites?
Topics: Adrenergic beta-Antagonists; Animals; Benzofurans; Calcium Chloride; Electric Stimulation; Female; Guinea Pigs; Ileum; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Potassium; Refractory Period, Electrophysiological; Reserpine; Trachea; Uterine Contraction | 1984 |
Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Arrhythmia Agents; Basal Ganglia; Benzofurans; Callithrix; Female; Glutamic Acid; In Vitro Techniques; Male; Motor Activity; Naltrexone; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Synaptic Transmission | 1995 |
Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism.
Topics: alpha-Methyltyrosine; Animals; Antiparkinson Agents; Benzeneacetamides; Benzofurans; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine | 1998 |
A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain.
Topics: Algorithms; Amphetamine; Animals; Benzazepines; Benzofurans; Brain; Brain Chemistry; Cerebellum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Ligands; Macaca fascicularis; Neocortex; Neostriatum; Receptors, Dopamine D1; Reserpine; Tomography, Emission-Computed | 1999 |
The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Benzofurans; Biogenic Monoamines; Clonidine; Disease Models, Animal; Drug Combinations; Drug Synergism; Locomotion; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease, Secondary; Prazosin; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Yohimbine | 1999 |
(-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release.
Topics: Amantadine; Animals; Antipsychotic Agents; Benzazepines; Benzofurans; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Habituation, Psychophysiologic; Male; Motor Activity; Oxidopamine; Rats; Rats, Wistar; Reserpine; Signal Transduction; Substantia Nigra | 2001 |
The L-DOPA-sparing effect of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(-)-BPAP] in reserpine-pretreated rats.
Topics: alpha-Methyltyrosine; Animals; Benzofurans; Drug Synergism; Levodopa; Male; Motor Activity; Rats; Rats, Wistar; Reserpine | 2003 |
Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
Topics: Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Animals; Benzazepines; Benzofurans; Binding Sites; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; Hippocampus; Male; Prefrontal Cortex; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Reserpine; Schizophrenia; Time Factors; Tritium | 2003 |
Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Benzazepines; Benzofurans; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Idazoxan; Imidazoles; Imidazoline Receptors; Injections, Intraperitoneal; Ligands; Male; Mice; Muscle Rigidity; Muscle, Skeletal; Parkinsonian Disorders; Reserpine; Time Factors; Yohimbine | 2008 |
Effects of imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats.
Topics: Analgesics; Animals; Benzofurans; Depression; Disease Models, Animal; Fibromyalgia; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Imidazolines; Male; Pain; Pain Measurement; Quinazolines; Rats; Rats, Sprague-Dawley; Reserpine | 2019 |